Journal article

The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis

Vinayak Singh, Stefano Donini, Angela Pacitto, Claudia Sala, Ruben C Hartkoorn, Neeraj Dhar, Gyorgy Keri, David B Ascher, Guillaume Mondesert, Anthony Vocat, Andreanne Lupien, Raphael Sommer, Helene Vermet, Sophie Lagrane, Joe Buechler, Digby F Warner, John D McKinney, Janos Pato, Stewart T Cole, Tom L Blundell Show all

ACS Infectious Diseases | AMER CHEMICAL SOC | Published : 2017

Grants

Awarded by European Community


Awarded by Senior International Research Scholar's grant from the HHMI


Awarded by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)


Awarded by NHMRC CJ Martin Fellowship


Awarded by Swiss National Science Foundation


Awarded by Medical Research Council


Funding Acknowledgements

This work was funded by the European Community's Seventh Framework Programme (Grant 260872); the South African Medical Research Council (to V.M.); the National Research Foundation of South Africa (to V.M.); a Senior International Research Scholar's grant from the HHMI (Grant 55007649 to V.M.); the Bill and Melinda Gates Foundation (to A.P. and T.L.B.), a Newton Fund RCUK-CONFAP grant awarded by The Medical Research Council (MRC) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (Grant MR/M026302/1 to T.L.B. and D.B.A.), a NHMRC CJ Martin Fellowship (Grant APP1072476 to D.B.A.); the Swiss National Science Foundation (31003A-162641) and the Fondation Beytout (to S.T.C.); the University of Cambridge and The Wellcome Trust for facilities and support (to T.L.B.).